ReShape Lifesciences Inc. (NASDAQ: RSLS)
$5.5700
+0.0200 ( +0.36% ) 0.0K
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Market Data
Open
$5.5700
Previous close
$5.5500
Volume
0.0K
Market cap
$3.96M
Day range
$5.5060 - $5.5500
52 week range
$4.6000 - $34.2200
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Apr 10, 2024 |
8-k | 8K-related | 15 | Apr 10, 2024 |
8-k | 8K-related | 15 | Apr 04, 2024 |
10-k | Annual reports | 88 | Apr 01, 2024 |
8-k | 8K-related | 14 | Feb 26, 2024 |
def | Proxies and info statements | 6 | Jan 24, 2024 |
8-k | 8K-related | 13 | Jan 18, 2024 |
3 | Insider transactions | 1 | Jan 16, 2024 |
pre | Proxies and info statements | 4 | Jan 05, 2024 |
8-k | 8K-related | 15 | Nov 29, 2023 |